LifeStance Health Group annual free cash flow
2019
2021
2022
2023
2024
2025
LifeStance Health Group Free Cash Flow (FCF) History (LFST)
LifeStance Health Group reported $110.0M in free cash flow for fiscal 2025, an increase of 28.39% from the previous fiscal year, with a free cash flow margin of 7.72%.
View full LifeStance Health Group company overviewLifeStance Health Group free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $110.0M | $24.3M | +28.39% | +7.72% |
| 2024 | 2024-12-31 | $85.7M | $143.1M | — | +6.85% |
| 2023 | 2023-12-31 | −$57.4M | −$30.9M | — | −5.44% |
| 2022 | 2022-12-31 | −$26.5M | $58.6M | — | −3.08% |
| 2021 | 2021-12-31 | −$85.1M | −$87.8M | — | −5887.34% |
| 2019 | 2019-12-31 | $2.7M | — | — | +1.29% |
LifeStance Health Group quarterly free cash flow
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $87.9M | $31.3M | +55.22% | +20.19% |
| Q1 2026 | 2026-03-31 | $22.3M | $32.6M | — | +5.54% |
| Q4 2025 | 2025-12-31 | $46.6M | −$9.4M | −16.72% | +12.21% |
| Q3 2025 | 2025-09-30 | $17.0M | −$675,000 | −3.82% | +4.67% |
| Q2 2025 | 2025-06-30 | $56.6M | $17.7M | +45.42% | +16.40% |
| Q1 2025 | 2025-03-31 | −$10.3M | $16.7M | — | −3.08% |
| Q4 2024 | 2024-12-31 | $56.0M | $50.6M | +940.98% | +17.21% |
| Q3 2024 | 2024-09-30 | $17.7M | $52.8M | — | +5.65% |
| Q2 2024 | 2024-06-30 | $39.0M | $51.0M | — | +12.47% |
| Q1 2024 | 2024-03-31 | −$26.9M | −$11.3M | — | −8.97% |
| Q4 2023 | 2023-12-31 | $5.4M | −$20.2M | −78.93% | +1.92% |
| Q3 2023 | 2023-09-30 | −$35.2M | −$25.8M | — | −13.37% |
| Q2 2023 | 2023-06-30 | −$12.0M | $6.0M | — | −4.63% |
| Q1 2023 | 2023-03-31 | −$15.6M | $9.0M | — | −6.18% |
| Q4 2022 | 2022-12-31 | $25.5M | $33.6M | — | +11.13% |
| Q3 2022 | 2022-09-30 | −$9.4M | $28.9M | — | −4.31% |
| Q2 2022 | 2022-06-30 | −$18.0M | $19.6M | — | −8.61% |
| Q1 2022 | 2022-03-31 | −$24.6M | −$23.4M | — | −12.11% |
| Q4 2021 | 2021-12-31 | −$8.0M | −$9.7M | — | — |
| Q3 2021 | 2021-09-30 | −$38.2M | $4.2M | — | −21.99% |
| Q2 2021 | 2021-06-30 | −$37.6M | — | — | −2775.59% |
| Q1 2021 | 2021-03-31 | −$1.2M | — | — | −0.82% |
| Q3 2020 | 2020-09-30 | $1.7M | — | — | +3761.36% |
| Q2 2020 | 2020-06-30 | −$42.4M | — | — | −265231.25% |
LifeStance Health Group free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $2.7M to $110.0M, a compound annual growth rate of 109.38%. LifeStance Health Group's latest reported quarter, Q2 2026, generated $87.9M in free cash flow, an increase of 55.22% year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review LifeStance Health Group filings at SEC.gov ↗